Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients
Zhujiang Hospital
Zhujiang Hospital
Haukeland University Hospital
The First Affiliated Hospital with Nanjing Medical University
CancerCare Manitoba
All India Institute of Medical Sciences, Bhubaneswar
University of Milano Bicocca
The Christie NHS Foundation Trust
Oslo University Hospital
Assistance Publique Hopitaux De Marseille
Beijing Tsinghua Chang Gung Hospital
University Medical Center Groningen
Prof. Franciszek Lukaszczyk Memorial Oncology Center
University of Aarhus
Emory University
Guy's and St Thomas' NHS Foundation Trust
Second Affiliated Hospital of Nanchang University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Kyorin University
Second Affiliated Hospital, School of Medicine, Zhejiang University
University of Louisville
Second Affiliated Hospital, School of Medicine, Zhejiang University
Beijing Tiantan Hospital
Radboud University Medical Center
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Sun Yat-sen University
The Second Hospital of Hebei Medical University
Istituto Clinico Humanitas
Henan Provincial People's Hospital
Henan Provincial People's Hospital
Zhongnan Hospital
Global Neurosciences Institute
Centre Leon Berard
University of Göttingen
University of Oxford
Ruijin Hospital
Huashan Hospital
Beijing Tiantan Hospital
Fudan University
Huashan Hospital
Radboud University Medical Center
The Affiliated Hospital of Qingdao University
Zhongnan Hospital
Amsterdam UMC, location VUmc
Neuromed IRCCS
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Egyptian Medical Syndicate
Centre Hospitalier Universitaire Vaudois
Radboud University Medical Center
Tianjin Huanhu Hospital